Munich 2001, Second Annual
Conference ASTP
'Facing the Facts'
|
Introduction
Following the success of
our first conference, the second annual conference of ASTP promises to be
another memorable event. Munich was chosen not only for it’s beauty as a
city but for it’s significant contributions to the technology transfer sector.
The European headquarters of the European Patent Office is located here with a
new facility scheduled to be constructed soon. Additionally, Munich is situated
in the heart of the “Bavarian Valley” with its “Incubator,” which is emerging as
a prolific catalyst to innovation in the Biotechnology field, bringing together
the best of science, business and entrepreneurship from the region and beyond.
An optional trip to this area is available prior to the start of the conference
and we encourage everyone to go!
|
 |
Another landmark to this
year’s conference is the presentation of results on the first European Survey of
Science-based Technology Transfer Facts and Figures. Hundreds of surveys were
sent throughout Europe to collect quantitative insights into the financial and
economic impact for university technology transfer: patents, licences,
start-ups, invention disclosures and contract research to name just a few of the
issues queried on our survey. The results will be discussed by European
speakers as well as comparative examples given by experts from the United States
who will address the problems they have overcome to gain their current
knowledge.
At the heart of the
conference are topics of universal importance such as the most recent
developments to date coupled with the day to day problems to solve when managing
university-industry technology transfer, e.g. internal organisation, patent law,
and the specific and innovative complexities of strategic alliances and the
valuation of ICT and biotech technologies.
Social Program
Wednesday, 30 May 2001, Visit to
the ‘Bavaria Valley’
The
BioTech-Region München is one of Europe’s most well known centres for
biotechnology. It has made a name for itself through the special potential it
offers for excellent biotechnological research and its targeted implementation
in start-up companies and industry. The so called ‘Bavaria
Valley’, centred in Martinsried, is developing at a particularly dynamic rate
and has currently over 120 pharmaceutical and biotechnology companies. A
remarkable number of new business are founded here every day, due to a
first-rate scientific environment, a large number of international VC companies
and attractive financing instruments provided by both the German Federal
Government and the State of Bavaria. In the past three years the number of
employees in the BioTech business rose from 300 to 2500 people. During a
voluntary trip on Wednesday-afternoon, 30th of May, we will visit a selection of
companies in the Incubator of Martinsried.
To view the program, click here